Publications by authors named "Jeffrey Fessel"

Claim this Profile
P
Potential cure of Alzheimer's disease by reducing the level of Cdk5 using two drugs, each with a different modus operandi.
Jeffrey Fessel

J Alzheimers Dis Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
All GLP-1 Agonists Should, Theoretically, Cure Alzheimer's Dementia but Dulaglutide Might Be More Effective Than the Others.
Jeffrey Fessel

J Clin Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Special Issue "Pathophysiology and Treatment of Alzheimer's Disease".
Jeffrey Fessel

Int J Mol Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulating Treatment to Cure Alzheimer's Dementia: Approach #2.
Jeffrey Fessel

Int J Mol Sci· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized, Precision Medicine to Cure Alzheimer's Dementia: Approach #1.
Jeffrey Fessel

Int J Mol Sci· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The several ways to authentically cure Alzheimer's dementia.
Jeffrey Fessel

Ageing Res Rev· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Why Alzheimer's Dementia Never Spontaneously Reverses, Suggests the Basis for Curative Treatment.
Jeffrey Fessel

J Clin Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cure of Alzheimer's Dementia in Many Patients by Using Intranasal Insulin to Augment an Inadequate Counter-Reaction, Edaravone to Scavenge ROS, and 1 or 2 Other Drugs to Address Affected Brain Cells.
Jeffrey Fessel

J Clin Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cure of Alzheimer's Dementia Requires Addressing All of the Affected Brain Cell Types.
Jeffrey Fessel

J Clin Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supplementary Pharmacotherapy for the Behavioral Abnormalities Caused by Stressors in Humans, Focused on Post-Traumatic Stress Disorder (PTSD).
Jeffrey Fessel

J Clin Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluoxetine plus lithium for treatment of mental health impairment in Long Covid.
Jeffrey Fessel

Discov Ment Health· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulating treatment of major psychiatric disorders: algorithm targets the dominantly affected brain cell-types.
Jeffrey Fessel

Discov Ment Health· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abnormal oligodendrocyte function in schizophrenia explains the long latent interval in some patients.
Jeffrey Fessel

Transl Psychiatry· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversing Alzheimer's disease dementia with clemastine, fingolimod, or rolipram, plus anti-amyloid therapy.
Jeffrey Fessel

Alzheimers Dement (N Y)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supplemental thiamine as a practical, potential way to prevent Alzheimer's disease from commencing.
Jeffrey Fessel

Alzheimers Dement (N Y)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does synaptic hypometabolism or synaptic dysfunction, originate cognitive loss? Analysis of the evidence.
Jeffrey Fessel

Alzheimers Dement (N Y)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A vaccine to prevent initial loss of cognition and eventual Alzheimer's disease in elderly persons.
Jeffrey Fessel

Alzheimers Dement (N Y)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential for one drug, administered at the earliest preclinical stage, to prevent the subsequent decline of cognition that eventuates in dementia.
Jeffrey Fessel

Alzheimers Dement (N Y)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virological Failure and Acquired Genotypic Resistance Associated With Contemporary Antiretroviral Treatment Regimens.
Soo-Yon Rhee, Dana Clutter, C Bradley Hare, Christophe T Tchakoute, Kristin Sainani, W Jeffrey Fessel

Open Forum Infect Dis· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caveolae, CD109, and endothelial cells as targets for treating Alzheimer's disease.
Jeffrey Fessel

Alzheimers Dement (N Y)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
If ineffective levels of transforming growth factors and their receptor account for old age being a risk factor for Alzheimer's disease, then increasing TGFBR2 might be therapeutic.
Jeffrey Fessel

Alzheimers Dement (N Y)· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The paradox of opposite directions of gene expressions in MCI and AD suggests possible therapy to prevent progression of MCI to AD.
Jeffrey Fessel

Alzheimers Dement (N Y)· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ineffective levels of transforming growth factors and their receptor account for old age being a risk factor for Alzheimer's disease.
Jeffrey Fessel

Alzheimers Dement (N Y)· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of Alzheimer's disease by treating mild cognitive impairment with combinations chosen from eight available drugs.
Jeffrey Fessel

Alzheimers Dement (N Y)· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1.
Brinda Emu, Jeffrey Fessel, Shannon Schrader, Princy Kumar, Gary Richmond

N Engl J Med· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis